Preclinical evaluation of the RBD-Trimeric vaccine: A novel approach to strengthening biotechnological sovereignty in developing countries against SARS-CoV-2 variants

New immunogens against emerging new virus variants are essential for controlling new variants. Methods: A preclinical study in which a receptor-binding domain (RBD) trimer was designed in silico with information from the Beta (B.1.351), Omicron (BA.5), and Wuhan 1 variant. A three-dimensional model...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Luis Flórez, Daniel Echeverri-De la Hoz, Alfonso Calderón, Hector Serrano-Coll, Caty Martinez, Camilo Guzmán, Bertha Gastelbondo, German Arrieta, Ariel Arteta, Tania Márquez, Ricardo Rivero, Salim Máttar
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Elsevier 2025-03-01
סדרה:	Travel Medicine and Infectious Disease
נושאים:	Public health Biotechnology Social development Computational biology Preventive medicine Vulnerable populations
גישה מקוונת:	http://www.sciencedirect.com/science/article/pii/S1477893925000262
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!